Target Name: MIR1238
NCBI ID: G100302226
Review Report on MIR1238 Target / Biomarker Content of Review Report on MIR1238 Target / Biomarker
MIR1238
Other Name(s): MIRN1238 | MicroRNA 1238 | hsa-miR-1238-3p | microRNA 1238 | hsa-mir-1238 | hsa-miR-1238-5p

MIR1238: A Drug Target / Disease Biomarker

MIR1238, also known as interleukin-1238, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin-12 family, which is a group of cytokines that play a crucial role in the immune system. MIR1238 has been shown to have various biological functions, including regulating inflammation, promoting tissue repair, and influencing cellular processes such as cell adhesion and migration.

One of the key functions of MIR1238 is its role in the immune response. MIR1238 has been shown to regulate the production of T cells, which are a crucial part of the immune system. T cells are responsible for recognizing and responding to foreign substances in the body, and MIR1238 plays a key role in ensuring that they are properly equipped to carry out their duties.

In addition to its role in immune regulation, MIR1238 has also been shown to have other biological functions that are important for overall health. For example, it has been shown to promote tissue repair and regeneration after injury or disease. This is important because injuries and diseases can cause significant damage to tissues, and it is important for the body to repair and regenerate them in order to restore function and prevent long-term disability.

MIR1238 has also been shown to influence cellular processes such as cell adhesion and migration. This is important because cells are able to move and stick to specific locations in the body in order to carry out their functions, and MIR1238 plays a key role in regulating these processes. MIR1238 has been shown to help cells stick to the surface of other cells, which is important for maintaining tissue structure and function.

Another function of MIR1238 is its role in inflammation. MIR1238 has been shown to help regulate the production of pro-inflammatory cytokines, which are molecules that contribute to inflammation. This is important because chronic inflammation can contribute to a range of diseases, including heart disease, cancer, and autoimmune disorders. By helping to regulate inflammation, MIR1238 may help to reduce the risk of these diseases.

In addition to its role in immune and inflammatory regulation, MIR1238 has also been shown to have other biological functions. For example, it has been shown to play a key role in the development and maintenance of cancer. This is important because cancer is a major cause of death and disability, and understanding how MIR1238 contributes to cancer development may help to identify potential therapeutic targets.

MIR1238 has also been shown to have potential as a drug target. Several studies have shown that MIR1238 can be targeted by small molecules, which can be used to inhibit its functions. This suggests that MIR1238 may be an attractive target for new drugs that are being developed for various diseases.

In conclusion, MIR1238 is a protein that has been shown to have various biological functions, including regulating the immune system, promoting tissue repair and regeneration, influencing cellular processes such as cell adhesion and migration, and playing a key role in the development and maintenance of cancer. Its potential as a drug target makes it an attractive target for researchers to investigate further. Further studies are needed to fully understand the functions of MIR1238 and its potential as a therapeutic target.

Protein Name: MicroRNA 1238

The "MIR1238 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1238 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307